The BC-CfE’s Committee for Drug Evaluation and Therapy has issued and continues to update guidelines regarding SARS-CoV-2 and Persons Living with HIV. Please click the link below to see these statements.
All samples submitted for Drug Resistance Testing will now be tested for susceptibility to Protease and Reverse Transcriptase Inhibitors (nRTIs, NNRTIs, PIs) and Integrase Inhibitors. Separate requests are still required for GP41 drug resistance testing (susceptibility to Fusion Inhibitors) and HIV Coreceptor tropism testing (susceptibility to CCR5 antagonists). Updated requisition forms are available here .
RT @CIHR_CTN : Did you know that over 50% of Canadians living with HIV are now over the age of 50? Learn about HIV and aging from… https://t.co/dHfzNlV1Eu 1 month ago
Canada's #1 LGBTQ+ Online PrEP Clinic - Freddie